Beckman Coulter Life Sciences has acquired Blue Ocean Biomedical, LLC, a Pembroke Pines, Florida-based manufacturer of automated flow cytometry systems and reagents. The transaction provides Beckman Coulter Life Sciences with low complexity analyzers that integrate automated sample preparation and directly address emerging flow cytometry market trends. Driving growth through internal product development and through acquisition […]
Tampa, FL – Innovaro, Inc (NYSE Amex: INV), The Innovation Solutions Company, is pleased to announce that its client Inven2, the technology transfer office at Oslo University Hospital and University of Oslo, has entered into an exclusive licensing agreement with Oxford Gene Technology (OGT) for 12 highly promising colorectal cancer tissue biomarkers through Innovaro’s Pharmalicensing […]
Stockholm, Sweden – March 28, 2012 – LingVitae, Plarion Ltd and KTH Royal Institute of Technology have today announced engagement into a collaborative development program aiming at utilising the new Discipher system for bringing DNA-based testing and diagnostics to point-of-care settings. “Our aim with the Discipher is to democratise molecular and cellular analysis, putting low-cost […]
SANTA CLARA, Calif. and SALT LAKE CITY,– Affymetrix, Inc. (NASDAQ: AFFX) and Lineagen, Inc., an innovative molecular diagnostics company focused on complex, genetically linked disorders, today announced the companies have signed an agreement to incorporate Affymetrix’ GeneChip® technology into Lineagen’s next-generation FirstStepDx, a genetic evaluation service for individuals with developmental delay (DD), intellectual disability (ID), […]
Leuven – p. Cartagenia, the global leader in supplying diagnostic knowledge, analytic software and database systems to genetic labs and clinicians, today announced the commercial release of its BENCH lab NGS solution for clinical NGS data analysis. p. The new product is tailored to support the adoption of Next Generation Sequencing technology in routine clinical […]
Cambridge, UK,: Horizon Diagnostics (HDx), a division of Horizon Discovery Limited, a leading provider of research tools to support the development and prescription of personalized medicines, today announced it has signed a strategic partnership agreement with the European Molecular Genetics Quality Network (EMQN). Under the terms of the agreement, HDx will provide genetically defined human […]
A*STAR Institute of Microelectronics (IME), has signed a research collaboration agreement with QuantuMDx Group (QMDx), a UK based biotech company which is developing a range of portable technologies for diagnostics, DNA sequencing and proteomics. Under this collaboration, IME will further advance QMDx’s DNA sequencing nanowire biosensor to the point of commercialization. QMDx is pioneering a […]
Shanghai, China, – QIAGEN today announced that it has signed an agreement with Bio-X Center of Shanghai Jiao Tong University to open a joint translational medicine lab in Shanghai. The lab is the first of its kind between QIAGEN and a major research institution in China and is a key milestone in the Company’s expansion […]
PORTAGE, Mich — Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its immunodiagnostics business has received 510(k) clearance of the Thermo Scientific ImmunoCAP Tryptase Assay for use on its Thermo Scientific Phadia Laboratory Systems line of automated laboratory instruments. ImmunoCAP Tryptase is the first commercially available assay in the U.S. […]
A study to be published in the journal Clinical Chemistry has shown that a high sensitivity cardiac troponin-I (cTnI) assay from Singulex, Inc. could be used to identify, in healthy asymptomatic people, an increased risk of dying from cardiovascular disease (CVD) eight to 15 years in the future. This proprietary assay (Erenna® cTnl Immunoassay) is […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
